Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Clinical Data
  • Beam posts positive data on base editing treatment for AATD
  • Clinical Data

Beam posts positive data on base editing treatment for AATD

BioPharma Dive

Updated data showed the biotech's approach to the rare lung and liver condition helped restore functional protective proteins in a small study.

Clinical DataRare DiseaseRead full story

pharminent March 25, 2026 (Last updated: March 26, 2026)

BioPharma Dive

Updated data showed the biotech’s approach to the rare lung and liver condition helped restore functional protective proteins in a small study.

Clinical DataRare DiseaseRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Sarepta sees early success with RNAi drugs from Arrowhead
Next: Maze tumbles despite positive data for kidney disease drug

Related Stories

  • Clinical Data

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma

pharminent June 2, 2026
  • Clinical Data

ASCO26: In vivo oncology approaches continue to show promise

pharminent June 2, 2026
  • Clinical Data

ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come

pharminent June 2, 2026

You May Have Missed

  • Policy / Pricing

Eli Lilly issues data sharing ultimatum to 340B hospitals

pharminent June 2, 2026
  • M&A / Deals

Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug

pharminent June 2, 2026
  • Clinical Data

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma

pharminent June 2, 2026
  • Clinical Data

ASCO26: In vivo oncology approaches continue to show promise

pharminent June 2, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.